Glenmark Pharmaceuticals

Glenmark Signs License Pact With Jiangsu Alphamab, 3D Medicines For Cancer Drug

Glenmark Pharma Shares Decline Over 6% After Rs 5,651 Crore Stake Sale Deal With Nirma

Glenmark Life Sciences IPO To Open On July 27, Plans To Raise Rs 1514 Crore

Glenmark Launches Covid-19 Drug After Approval From DGCA; Priced At Rs 103 Per Tablet